Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival
Abstract Background The anticancer drug paclitaxel is primarily metabolized in the liver. Previous studies have indicated a correlation between impaired liver function and paclitaxel toxicity, which may indicate dose reduction. Since the evidence is limited, the aim of this study was to investigate...
Salvato in:
| Autori principali: | , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2024-12-01
|
| Serie: | BMC Cancer |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s12885-024-13330-2 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|